GATA3 expression in morphologic subtypes of breast carcinoma: A comparison with gross cystic disease fluid protein 15 and mammaglobin

Annals of Diagnostic Pathology

Volumn 19, Issue 1, 2015, Pages 6-9

  Wendroth, Scott M ^a   Mentrikoski, Mark J ^a   Wick, Mark R ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

breast carcinomas; GATA3; GCDFP 15; immunohistochemistry; mammaglobin

Indexed keywords

ESTROGEN RECEPTOR; GROSS CYSTIC DISEASE FLUID PROTEIN 15; MAMMAGLOBIN; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR GATA 3; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; GATA3 PROTEIN, HUMAN; GLYCOPROTEIN; MAMMAGLOBIN A; PIP PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; BREAST CARCINOMA; BREAST MEDULLARY CARCINOMA; BREAST METAPLASTIC CARCINOMA; CANCER MORPHOLOGY; CANCER PATIENT; CELL LABELING; CLINICAL ARTICLE; COLLOID CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MEDULLARY CARCINOMA; MORPHOMETRICS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SIGNET RING CARCINOMA; TISSUE MICROARRAY; TUMOR VOLUME; BIOSYNTHESIS; BREAST TUMOR; CLASSIFICATION; COHORT ANALYSIS; COMPARATIVE STUDY; IMMUNOHISTOCHEMISTRY; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY; PROCEDURES;

ADENOCARCINOMA, MUCINOUS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARRIER PROTEINS; COHORT STUDIES; FEMALE; GATA3 TRANSCRIPTION FACTOR; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMAGLOBIN A; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84922880847     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2014.12.001     Document Type: Article

References (29)

1. P.P. Pandolfi, M.E. Roth, A. Karis, M.W. Leonard, E. Dzierzak, and F.G. Grosveld Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis Nat Genet 11 1995 40 44
2. D.L. Bates, Y. Chen, G. Kim, L. Guo, and L. Chen Crystal structures of multiple GATA zinc fingers bound to DNA reveal new insights into DNA recognition and self-association by GATA J Mol Biol 381 2008 1292 1306
3. C.K. Kaufman, P. Zhou, H.A. Pasolli, M. Rendl, D. Bolotin, and K.C. Lim GATA-3: an unexpected regulator of cell lineage determination in skin Genes Dev 17 2003 2108 2122
4. D. Grote, A. Souabni, M. Busslinger, and M. Bouchard Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney Development 133 2006 53 61
5. R. Martinez-Monedero, E. Yi, K. Oshima, E. Glowatzki, and A.S. Edge Differentiation of inner ear stem cells to functional sensory neurons Dev Neurobiol 68 2008 669 684
6. K. Tsarovina, A. Pattyn, J. Stubbusch, F. Muller, J. van der Wees, and C. Schneider Essential role of Gata transcription factors in sympathetic neuron development Development 131 2004 4775 4786
7. H. Kouros-Mehr, E.M. Slorach, M.D. Sternlicht, and Z. Werb GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland Cell 127 2006 1041 1055
8. M.L. Asselin-Labat, K.D. Sutherland, H. Barker, R. Thomas, M. Shackleton, and N.C. Forrest Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation Nat Cell Biol 9 2007 201 209
9. J. Usary, V. Llaca, G. Karaca, S. Presswala, M. Karaca, and X. He Mutation of GATA3 in human breast tumors Oncogene 23 2004 7669 7678
10. T.D. Tlsty Luminal cells GATA have it Nat Cell Biol 9 2007 135 136
11. P. Parikh, J.P. Palazzo, L.J. Rose, C. Daskalakis, and R.J. Weigel GATA-3 expression as a predictor of hormone response in breast cancer J Am Coll Surg 200 2005 705 710
12. N.K. Yoon, E.L. Maresh, D. Shen, Y. Elshimali, S. Apple, and S. Horvath Higher levels of GATA3 predict better survival in women with breast cancer Hum Pathol 41 2010 1794 1801
13. D. Voduc, M. Cheang, and T. Nielsen GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value Cancer Epidemiol Biomarkers Prev 17 2008 365 373
14. H.E. Gulbahce, C. Sweeney, M. Surowiecka, D. Knapp, L. Varghese, and C.K. Blair Significance of GATA-3 expression in outcomes of patients with breast cancer who received systemic chemotherapy and/or hormonal therapy and clinicopathologic features of GATA-3-positive tumors Hum Pathol 44 2013 2427 2431
15. N.G. Ordonez Value of GATA3 immunostaining in tumor diagnosis: a review Adv Anat Pathol 20 2013 352 360
16. M. Miettinen, P.A. McCue, M. Sarlomo-Rikala, J. Rys, P. Czapiewski, and K. Wazny GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors Am J Surg Pathol 38 2014 13 22
17. H. Liu, J. Shi, M.L. Wilkerson, and F. Lin Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas Am J Clin Pathol 138 2012 57 64
18. M.H. Luo, Y.H. Huang, Y.B. Ni, J.Y. Tsang, S.K. Chan, and M.M. Shao Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas Hum Pathol 44 2013 1241 1250
19. S. Darb-Esfahani, G. von Minckwitz, C. Denkert, B. Ataseven, B. Hogel, and K. Mehta Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes BMC Cancer 14 2014 546 556
20. D.R. Braxton, C. Cohen, and M.T. Siddiqui Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens Diagn Cytopathol 2014 [Epub ahead of print]
21. J.L. Bevilacqua, M.W. Kattan, J.V. Fey, H.S. Cody III, P.I. Borgen, and K.J. Van Zee Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation J Clin Oncol 25 2007 3670 3679
22. E. Yoshihara, A. Smeets, A. Laenen, A. Reynders, J. Soens, and C. Van Ongeval Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice Breast 22 2013 357 361
23. M. Yang, X. Li, P. Chun-Hong, and H. Lin-Ping Pure mucinous breast carcinoma: a favorable subtype Breast Care (Basel) 8 2013 56 59
24. S. Vranic, F. Schmitt, A. Sapino, J.L. Costa, S. Reddy, and M. Castro Apocrine carcinoma of the breast: a comprehensive review Histol Histopathol 28 2013 1393 1409
25. T. Bedford, A. Alperstein, Y. Nathani, R. Marx, and P. DeVito A rare presentation of triple-negative apocrine breast carcinoma with metastases J Surg Case Rep 2014 [online publication]
26. C. Reyes, C. Gomez-Fernandez, and M. Nadji Metaplastic and medullary mammary carcinomas do not express mammaglobin Am J Clin Pathol 137 2012 747 752
27. M.V. Dieci, E. Orvieto, M. Dominici, P. Conte, and V. Guarneri Rare breast cancer subtypes: histological, molecular, and clinical peculiarities Oncologist 19 2014 805 813
28. G. Mazoujian, C. Bodian, D.E. Haagensen Jr., and C.D. Haagensen Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors Cancer 63 1989 2156 2161
29. A.C. Chen, A.C. Paulino, M.R. Schwartz, A.A. Rodriguez, B.L. Bass, and J.C. Chang Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast Br J Cancer 111 2014 619 622